Covidien (NYSE: COV), a leading global provider of healthcare products, will present at the 31 st Annual J.P. Morgan Healthcare Conference in San Francisco, California, on January 7, 2013. Joe Almeida, Chairman, President and Chief Executive Officer, will discuss the Company in a presentation scheduled to begin at 8:30AM PT (11:30AM ET).
A live audio webcast of the presentation can be accessed at Covidien’s Investor Relations website: http://investor.covidien.com. An archived edition of the presentation will be available following the live webcast.
Covidien is a leading global healthcare products company that creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence. Covidien manufactures, distributes and services a diverse range of industry-leading product lines in three segments: Medical Devices, Pharmaceuticals and Medical Supplies. With 2012 revenue of $11.9 billion, Covidien has 43,000 employees worldwide in 70 countries, and its products are sold in over 140 countries. Please visit www.covidien.com to learn more about our business.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts